This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Nasdaq (NDAQ) November Volumes Increase Year Over Year
by Zacks Equity Research
Nasdaq (NDAQ) November 2021 volume reflects increase in U.S. equity options volume as well as higher European equity volume and European fixed income volume.
CME Group (CME) November ADV Increases at Four Product Lines
by Zacks Equity Research
CME Group's (CME) average daily volume of 23.1 million contracts per day increases 20% year over year due to higher volumes in four of the six product lines.
Why It's Worth Betting on Intercontinental (ICE) Stock Now
by Zacks Equity Research
Expansive product and service portfolio and solid balance sheet poise Intercontinental Exchange (ICE) well for growth.
Cboe Global (CBOE) Stock Gains 41% YTD: More Room for Growth?
by Zacks Equity Research
Increased medium-term target, strong market position, global reach, strength in its proprietary products, and solid capital position continue to drive Cboe Global (CBOE).
Cboe Global (CBOE) Raises Medium-Term Financial Target
by Zacks Equity Research
Cboe Global (CBOE) expects to deliver total net revenue growth of 5-7% annually, an increase from 4-6% growth expected earlier.
Cboe Global (CBOE) to Expand in Canada With Aequitas Buyout
by Zacks Equity Research
Cboe Global's (CBOE) pending buyout of Aequitas Innovations also known as NEO is likely to broaden its North American equities business.
OTC Markets Group Inc. (OTCM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of 34.78% and 13.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
OTC Markets Group Inc. (OTCM) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) Futures Products Aid Amid Cost Concerns
by Zacks Equity Research
CME Group (CME) holds potential to reap benefits driven by expansion of futures products, strong global presence, prudent capital deployment and sufficient liquidity position.
Reasons Why Cboe Global (CBOE) Stock is a Solid Pick Now
by Zacks Equity Research
Cboe Global (CBOE) is set to grow on higher market volumes, strategic acquisitions and effective capital deployment.
Intercontinental Exchange (ICE) Q3 & September Volumes Up Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) Q3 average daily volumes reflect higher volumes in Commodities as well as Financials.
CME Group (CME) Q3, September Volumes Up in Two Product Lines
by Zacks Equity Research
CME Group's (CME) Q3 average daily volumes reflect higher volumes in two of the six product lines.
Here's Why Investing in Nasdaq (NDAQ) is a Prudent Move Now
by Zacks Equity Research
Nasdaq (NDAQ) is well poised on the back of organic growth in proprietary data products, effective capital deployment, and improved liquidity position.
MarketAxess (MKTX) Offers Global Investors Access to CIBM
by Zacks Equity Research
MarketAxess (MKTX) launches trading channel in a bid to pave the way for seamless and effective trading of Chinese bonds by foreign investors. The move aims to tap ample growth prospects of CIBM.
Here's Why You Should Hold Intercontinental (ICE) Stock
by Zacks Equity Research
Intercontinental Exchange (ICE) is poised to grow, attributable to growth in fixed income data and analytics products and adoption of digital workflow tools across origination technology.
Cboe Global (CBOE) Subsidiary to Unveil Algo Execution
by Zacks Equity Research
Cboe Global's (CBOE) subsidiary set to launch an algorithmic execution service to boost the Global FX segment.
Intercontinental Exchange (ICE) August Volumes Rise Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) August ADV of 5.4 million contracts per day was up 12.3% year over year driven by higher volumes in Commodities, partly offset by lower Financials.
Intercontinental Exchange (ICE) to Launch Micro MSCI Futures
by Zacks Equity Research
Intercontinental Exchange (ICE) to launch micro-sized futures contracts to boost its Trading and Clearing Segment.
Nasdaq (NDAQ) Reports Mixed Volumes for August, Shares Down
by Zacks Equity Research
Nasdaq (NDAQ) August 2021 volume reflects increase in U.S. equity options volume but decrease in European options and futures volume.
CME Group (CME) August ADV Increases at Three Product Lines
by Zacks Equity Research
CME Group's (CME) average daily volume of 17.5 million contracts per day increases 7% year over year due to higher volumes in three of the six product lines.
Cboe Global (CBOE) Stock Up 37% YTD: More Room for Upside?
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products, and solid capital position continue to drive Cboe Global (CBOE).
Cboe Global (CBOE) to Share More Profits, Ups Dividend by 14%
by Zacks Equity Research
Cboe Global's (CBOE) recent dividend hike reflects its intention to enhance shareholders' value supported by strong financial position.
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Nasdaq and OTC Markets Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Nasdaq and OTC Markets Group
4 Securities and Exchanges to Watch Out For Amid Industry Challenges
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CBOE, CME, NDAQ and OTCM. However, compliance with regulations remains a challenge.
OTC Markets Group Inc. (OTCM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) delivered earnings and revenue surprises of 47.50% and 35.23%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?